Cartesian Therapeutics, Inc. RNAC
- Descartes-08 — Myasthenia Gravis Phase 3
- Descartes-08 — Dermatomyositis Phase 1
- Descartes-08 — Antisynthetase Syndrome Phase 2
- Descartes-15 — Multiple Myeloma Phase 1
BCMA (8 companies · 14 programs)
Companies with an active program directed at BCMA.
Cullinan Therapeutics, Inc. CGEM
- velinotamig — Systemic Lupus Erythematosus Phase 1
- velinotamig — Immune Thrombocytopenia Phase 1
- velinotamig — Autoimmune Hemolytic Anemia Phase 1
Autolus Therapeutics plc AUTL
- AUTO8 — Relapsed/Refractory Multiple Myeloma Phase 1
- AUTO8 — Light Chain Amyloidosis Phase 1
Allogene Therapeutics, Inc. ALLO
- ALLO-715 — Multiple Myeloma
Caribou Biosciences, Inc. CRBU
- CB-011 — Relapsed/Refractory Multiple Myeloma Phase 1
Immix Biopharma, Inc. IMMX
- NXC-201 — Relapsed/Refractory AL Amyloidosis Phase 2
MiNK Therapeutics, Inc. INKT
- MiNK-413 Preclinical
Sana Biotechnology, Inc. SANA
- SG227 — Multiple Myeloma Preclinical